Portola Pharmaceuticals, Inc. announced the appointment of David C. Stump, M.D., to its board of directors. Dr. Stump most recently served as executive vice president, research and development, at Human Genome Sciences, Inc.
Portola Pharmaceuticals, Inc.
Equities
US7370101088
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+51.85% | 57.87B | |
+41.42% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B |